Home/Filings/4/0001104659-15-013084
4//SEC Filing

AGILE THERAPEUTICS INC 4

Accession 0001104659-15-013084

CIK 0001261249operating

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:58 PM ET

Size

5.3 KB

Accession

0001104659-15-013084

Insider Transaction Report

Form 4
Period: 2015-02-19
MacFarlane Katie
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-02-19+21,00021,000 total
    Exercise: $9.45Exp: 2025-02-18Common Stock (21,000 underlying)
Footnotes (1)
  • [F1]This option was granted on February 19, 2015. 25% of the shares subject to the stock option vest on February 19, 2016, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on February 19, 2019.

Documents

1 file

Issuer

AGILE THERAPEUTICS INC

CIK 0001261249

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001261249

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:58 PM ET
Size
5.3 KB